Waiting for an elevated FSH - Too late a marker of reduced ovarian reserve?

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 52, Issue 5, 2012, Pages 460-464

  Kahapola Arachchige, Kalani Mudhitha ^a   Wardrop, Robert ^b   Lim, Ee Mun ^b   Stuckey, Bronwyn ^b,c,d   Hadlow, Narelle ^a,b  

^a WESTERN DIAGNOSTIC PATHOLOGY   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c Keogh Institute for Medical Research   (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

fertility; follicular stimulating hormone; median age; ovarian reserve; poor predictor

Indexed keywords

ESTRADIOL; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; FALLING; FEMALE; FOLLITROPIN BLOOD LEVEL; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; OVARIAN RESERVE; PREGNANT WOMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; FERTILITY; FOLLICLE STIMULATING HORMONE; HUMANS; INFANT; MIDDLE AGED; OVARIAN FUNCTION TESTS; OVARY; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84867559507     PISSN: 00048666     EISSN: 1479828X     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2012.01464.x     Document Type: Article

References (34)

1. Van Noord-Zaadstra BM, Looman CW, Alsbach H, et al,. Delaying childbearing: effect of age on fecundity and outcome of pregnancy. BMJ 1991; 302 (6789): 1361-1365.
2. Broekmans FJ, Soules MR, Fauser BC,. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009; 30 (5): 465-493.
3. Dunson DB, Colombo B, Baird DD,. Changes with age in the level and duration of fertility in the menstrual cycle. Hum Reprod 2002; 17 (5): 1399-1403.
4. Rowe T,. Fertility and a woman's age. J Reprod Med 2006; 51 (3): 157-163.
5. Macklon NS, Fauser BCJM,. Ovarian reserve. Semin Reprod Med 2005; 23 (3): 248-256.
6. Australian Bureau of Statistics. Australia's Babies in Australian Social Trends, Catalogue no. 4102.0. Canberra: Australian Bureau of Statistics, 2007.
7. Faddy MJ, Gosden RG, Gougeon A, et al,. Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 1992; 7 (10): 1342-1346.
8. Evers JLH,. Female Subfertility. Lancet 2002; 360 (9327): 151-159.
9. Barad DH, Weghofer A, Gleicher N,. Utility of age-specific serum anti-Mullerian hormone concentrations. Reprod Biomed Online 2011; 22 (3): 284-291.
10. La Marca A, Broekmans FJ, Volpe A, et al,. Anti-Mullerian hormone (AMH): what do we still need to know? Hum Reprod 2009; 24 (9): 2264-2275.
11. Kelsey TW, Wright P, Nelson SM, et al,. A validated model of serum anti-mullerian hormone from conception to menopause. PLoS ONE 2011; 6 (7): e22024.
12. De Vet A, Laven JSE, De Jong FH, et al,. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002; 77 (2): 357-362.
13. Van Rooij IAJ, Broekmans FJM, Scheffer GJ, et al,. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril 2005; 83 (4): 979-987.
14. Scott RT, Toner JP, Muasher SJ, et al,. Follicle-stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril 1989; 51 (4): 651-654.
15. Scott RT Jr, Hofmann GE,. Prognostic assessment of ovarian reserve. Fertil Steril 1995; 63 (1): 1-11.
16. Sharara FI, Scott RT Jr, Seifer DB,. The detection of diminished ovarian reserve in infertile women. Am J Obstet Gynecol 1998; 179 (3 Pt 1): 804-812.
17. Klein NA, Battaglia DE, Fujimoto VY, et al,. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab 1996; 81 (3): 1038-1045.
18. Bancsi LFJMM, Broekmans FJM, Mol BWJ, et al,. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in vitro fertilization: a meta-analysis. Fertil Steril 2003; 79 (5): 1091-1100.
19. Broekmans FJ, Kwee J, Hendriks DJ, et al,. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 2006; 12 (6): 685-718.
20. Van der Steeg JW, Steures P, Eijkemans MJC, et al,. Predictive value and clinical impact of Basal follicle-stimulating hormone in subfertile, ovulatory women. J Clin Endocrinol Metab 2007; 92 (6): 2163-2168.
21. Burger HG, Dudley EC, Hopper JL, et al,. Prospectively measured levels of serum follicle-stimulating hormone, estradiol, and the dimeric inhibins during the menopausal transition in a population-based cohort of women. J Clin Endocrinol Metab 1999; 84 (11): 4025-4030.
22. Van der Steeg JW, Steures P, Eijkemans MJC, et al,. Pregnancy is predictable: a large-scale prospective external validation of the prediction of spontaneous pregnancy in subfertile couples. Hum Reprod 2007; 22 (2): 536-542.
23. National Health and Medical Research Council, Australian Research Council, Australian Vice-Chancellors' Committee. National statement on ethical conduct in human research. Canberra: Australian Government, 2007. chapter 5.1.22(b).
24. Bland M, ed. An Introduction to Medical Statistics. Oxford: Oxford Medical Publications, 1987.
25. Treloar AE,. Menstrual cyclicity and the pre-menopause. Maturitas 1981; 3 (3-4): 249-264.
26. Ledger WL,. Clinical utility of measurement of anti-mullerian hormone in reproductive endocrinology. J Clin Endocrinol Metab 2010; 95 (12): 5144-5154.
27. Hehenkamp WJK, Looman CWN, Themmen APN, et al,. Anti-Mullerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab 2006; 91 (10): 4057-4063.
28. Tsepelidis S, Devreker F, Demeestere I, et al,. Stable serum levels of anti-Mullerian hormone during the menstrual cycle: a prospective study in normo-ovulatory women. Hum Reprod 2007; 22 (7): 1837-1840.
29. Cook CL, Siow Y, Taylor S, Fallat ME,. Serum mullerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 2000; 73 (4): 859-861.
30. Wunder DM, Bersinger NA, Yared M, et al,. Statistically significant changes of anti mullerian hormone and inhibin levels during the physiologic menstrual cycle in reproductive age women. Fertil Steril 2008; 89 (4): 927-933.
31. Sowers M, McConnell D, Gast K, et al,. Anti-Mullerian hormone and inhibin B variability during normal menstrual cycles. Fertil Steril 2010; 94 (4): 1482-1486.
32. Barad DH, Weghofer A, Gleicher N,. Age-specific levels for basal follicle-stimulating hormone assessment of ovarian function. Obstet Gynecol 2007; 109 (6): 1404-1410.
33. Fang J, Metter EJ, Landis P, et al,. Low levels of prostate-specific antigen predict long-term risk of prostate cancer: results from the Baltimore Longitudinal Study of Aging. Urology 2001; 58 (3): 411-416.
34. McKenzie P, Delahunt B, DeVoss K, et al,. Prostate specific antigen testing for the diagnosis of prostate cancer. Pathology 2011; 43 (5): 403.